Consensus Medicenna Therapeutics Corp.

Equities

Market Closed - Toronto S.E. Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
2.27 ^CAD	-4.22%		-8.10%	+440.48%

May. 13	Medicenna Says ABILITY-1 Abstract Withdrawn by ASCO Program Committee	MT
May. 13	Medicenna Brief: Providing Update on its Presentations at the 2024 ASCO Annual Meeting	MT

e2ee0.xEjAQqWKb4mNU8y1Tj4FHTxuMVrXBL5u0CcRU0rb78w.rSD4Etf6Xtn6EbjlKVF0Vl1cWz2_d4gIgX9gZX_2jKucCaYT0ac459sniQ~cb243bb132f2844c9b9fe80f5c2844ea

Oppenheimer Adjusts Medicenna Therapeutics Price Target to $3 From $8, Maintains Outperform Rating	23-08-14	MT
HC Wainwright Reiterates Medicenna Therapeutics at Buy With $2.50 Price Target	23-02-08	MT
HC Wainwright Adjusts Price Target on Medicenna Therapeutics to $2.50 From $4, Maintains Buy Rating	22-11-08	MT
HC Wainwright Adjusts Medicenna Therapeutics' Price Target to $4 From $5, Keeps Buy Rating	22-08-16	MT
Oppenheimer Adjusts Medicenna Therapeutics Price Target to $8 From $10, Maintains Outperform Rating	22-08-10	MT
HC Wainwright Adjusts Medicenna Therapeutics' Price Target to $5 from $7, Keeps Buy Rating	22-06-23	MT
Oppenheimer Adjusts Medicenna Therapeutics Price Target to $10 From $12, Maintains Outperform Rating	22-06-23	MT
MEDICENNA THERAPEUTICS : HC Wainwright Adjusts Price Target on Medicenna Therapeutics to $7 From $8, Maintains Buy Rating	21-06-01	MT
MEDICENNA THERAPEUTICS : Oppenheimer Starts Medicenna Therapeutics at Outperform With $12 Price Target	20-12-18	MT

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.27 CAD

Average target price

7 CAD

Spread / Average Target

+208.37%

High Price Target

9 CAD

Spread / Highest target

+296.48%

Low Price Target

5 CAD

Spread / Lowest Target

+120.26%

Oppenheimer
HC Wainwright